Hareket Bozukluklarında İleri MRI: Hastalığın Erken Tanı ve İzleme İlerlemesi İçin Umut Verici Bir Araç

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Advanced magnetic resonance imaging (MRI) techniques are transforming the study of movement disorders, offering unprecedented opportunities for early diagnosis, disease monitoring, and therapeutic evaluation. Emerging modalities such as neuromelanin-sensitive imaging, diffusion-weighted imaging, magnetization transfer imaging, and relaxometry provide sensitive biomarkers that can detect early microstructural degeneration, iron deposition, and connectivity disruptions in key regions like the substantia nigra. These techniques enable earlier and more accurate differentiation of movement disorders, including Parkinson’s disease, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, Lewy body and frontotemporal dementia, Huntington’s disease and dystonia. Furthermore, MRI provides objective metrics for tracking disease progression and assessing therapeutic efficacy, making it an indispensable tool in clinical trials. By integrating these methods, researchers can enhance the precision of neurodegeneration assessment and facilitate the development of personalized treatments for movement disorders.

İlgili konular